Jonathan Davis
Director of ADC DIscovery Helix Biotech
Seminars
Wednesday 25th February 2026
Next-Generation ADCs: Unlocking the Potential of CEACAM6-Directed Targeted Therapies
2:00 pm
- Examining CEACAM6 as a tumour-specific target in hard-to-treat solid tumours
- Leveraging cutting edge ADC design to achieve precise targeting with broad therapeutic potential
- Building state-of-the-art ADC constructs targeting CEACAM6
